Scientific work

Prof. Dr. Faysal Dane

278 publications. The source of the information is stated next to each publication.

Back to profile

  1. Prognostic value of modified Glasgow prognostic score in recurrent high-grade glial tumors treated with systemic treatment

    Clinical Neurology and Neurosurgery, 2020

    DOI 10.1016/j.clineuro.2020.105976 PMID 32531614 6 citations (OpenAlex) Source: OpenAlex

  2. Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study

    Journal of Oncology Pharmacy Practice, 2020

    DOI 10.1177/1078155220924075 PMID 32419618 12 citations (OpenAlex) Source: OpenAlex

  3. Long-term neuromusculoskeletal side effects and quality of life in nasopharyngeal cancer patients receiving radiochemotherapy

    European Archives of Oto-Rhino-Laryngology, 2020

    DOI 10.1007/s00405-020-05932-w PMID 32236708 4 citations (OpenAlex) Source: OpenAlex

  4. P-209 Multicenter real life experience of biological agents in patients with metastatic colorectal cancer

    Annals of Oncology, 2020

    DOI 10.1016/j.annonc.2020.04.291 Open-access full textSource: OpenAlex

  5. Clinicopathologic and Prognostic Differences between Three Different Age Groups (Child/Adolescent, Young Adults, and Adults) of Colorectal Cancer Patients: A Multicentre Study

    Oncology Research and Treatment, 2019

    DOI 10.1159/000502120 PMID 31437835 10 citations (Europe PMC) Open-access full textSource: OpenAlex

  6. The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study.

    PubMed, 2019

    PMID 31424664 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  7. Effect of PET/CT standardized uptake values on complete response to treatment before definitive chemoradiotherapy in stage III non-small cell lung cancer

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2019

    DOI 10.1007/s12094-018-1949-6 PMID 30229391 4 citations (Europe PMC) Open-access full textSource: Europe PMC

  8. Neoadjuvant treatment in patients with locally advanced gastric cancer.

    Journal of Clinical Oncology, 2019

    DOI 10.1200/jco.2019.37.4_suppl.127 3 citations (OpenAlex) Source: ORCID

  9. Impact of the Charlson Comorbidity Index on dose-limiting toxicity and survival in locally advanced and metastatic renal cell carcinoma patients treated with first-line sunitinib or pazopanib

    Journal of Oncology Pharmacy Practice, 2019

    DOI 10.1177/1078155219890032 PMID 31793376 12 citations (OpenAlex) Source: OpenAlex

  10. A rare case of primary rectal choriocarcinoma and review of the literature

    Journal of Oncology Pharmacy Practice, 2019

    DOI 10.1177/1078155219875510 PMID 31547751 9 citations (OpenAlex) Open-access full textSource: OpenAlex

  11. How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature

    Journal of Oncology Pharmacy Practice, 2019

    DOI 10.1177/1078155219879757 PMID 31615346 20 citations (OpenAlex) Open-access full textSource: OpenAlex

  12. Assessment of survival and prognostic factors in metastatic colorectal cancer patients treated with first-line bevacizumab-based therapy.

    PubMed, 2019

    PMID 31646797 6 citations (OpenAlex) Open-access full textSource: OpenAlex

  13. Glioblastomda İlk Seri Sistemik Tedavi

    Turkiye Klinikleri Medical Oncology - Special Topics, 2019

    Source: OpenAlex

  14. Beyin Tümörlerinde Beslenme

    Turkiye Klinikleri Medical Oncology - Special Topics, 2019

    Source: OpenAlex

  15. Primer Santral Sinir Sistemi Lenfomalarında Tanı, Evreleme ve Sistemik Tedavi

    Turkiye Klinikleri Medical Oncology - Special Topics, 2019

    Source: OpenAlex

  16. End-of-Life Considerations in Patients with Breast Cancer

    Springer eBooks, 2019

    DOI 10.1007/978-3-030-16792-9_33 Source: OpenAlex

  17. Effectiveness and Safety of LMWH Treatment in Patients With Cancer Diagnosed With Non-High-Risk Venous Thromboembolism: Turkish Observational Study (TREBECA)

    Clinical and Applied Thrombosis/Hemostasis, 2018

    DOI 10.1177/1076029617753538 PMID 29455568 4 citations (Europe PMC) Open-access full textSource: OpenAlex

  18. Prognostic factors in early stage lung cancer patients: Retrospective single center data.

    Journal of Clinical Oncology, 2018

    DOI 10.1200/jco.2018.36.15_suppl.e20500 Source: OpenAlex

  19. Retrospective evaluation of premenopausal hormone-sensitive breast cancer patients treated with adjuvant gonadotropin-releasing hormone analogue: Anatolian Society of Medical Oncology (ASMO) study

    Asia-Pacific Journal of Clinical Oncology, 2018

    DOI 10.1111/ajco.12685 PMID 28429422 1 citation (Europe PMC) Open-access full textSource: ORCID

  20. Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia

    OncoTargets and Therapy, 2018

    DOI 10.2147/ott.s106342 PMID 29403286 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  21. COMBINATION OF OxALIPLATIN, CAPECITABINE,t r a s t u z u m a b a n d c h e m o r a d io t h e r a p y INPATIENTS WITH GASTRIC CANCER

    AYBU AVESIS, 2018

    Source: OpenAlex

  22. Chordoma: a case series and review of the literature

    Journal of Medical Case Reports, 2018

    DOI 10.1186/s13256-018-1784-y PMID 30145982 34 citations (OpenAlex) Open-access full textSource: OpenAlex

  23. Bevacuzimab May Be Less Effective in Obese Metastatic Colorectal Cancer Patients

    Journal of Gastrointestinal Cancer, 2018

    DOI 10.1007/s12029-017-0047-2 PMID 29302856 19 citations (OpenAlex) Source: OpenAlex

  24. Kras-mutation influences outcomes for palliative primary tumor resection in advanced colorectal cancer-a Turkish Oncology Group study

    Surgical Oncology, 2018

    DOI 10.1016/j.suronc.2018.05.032 PMID 30217306 8 citations (OpenAlex) Open-access full textSource: OpenAlex

  25. A national, multicenter, non-interventional, observational study on treatment patterns in patients with metastatic renal cell carcinoma in Turkey – NOTES study

    OncoTargets and Therapy, 2018

    DOI 10.2147/ott.s148917 PMID 29551901 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  26. Quality of life study in patients with unresectable locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel versus gemcitabine alone:ax-panc-sy001: A phase II randomized study.

    Journal of Clinical Oncology, 2018

    DOI 10.1200/jco.2018.36.4_suppl.346 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  27. Analysis of feasibility of geriatric assessment tools in elderly cancer patients and effects on anti-cancer treatment planning.

    Journal of Clinical Oncology, 2018

    DOI 10.1200/jco.2018.36.15_suppl.e22028 2 citations (OpenAlex) Source: OpenAlex

  28. Effectiveness and safety of LMWH treatment in patients with cancer diagnosed with nonhigh-risk venous thromboembolism (VTE): Results of the Turkish observational study (TREBECA).

    Journal of Clinical Oncology, 2017

    DOI 10.1200/jco.2017.35.15_suppl.e21656 Source: OpenAlex

  29. EFFECTIVENESS AND SAFETY OF LMWH TREATMENT IN CANCER PATIENTS DIAGNOSED WITH NON-HIGH RISK VENOUS THROMBOEMBOLISM (VTE) - RESULTS OF TURKISH OBSERVATIONAL STUDY (TREBECA)

    Bursa Uludag University - AVESIS, 2017

    Source: OpenAlex

  30. EGFR-targeted treatments in patients with metastatic colorectal cancer: Experience of panitumumab.

    Journal of Clinical Oncology, 2017

    DOI 10.1200/jco.2017.35.15_suppl.e15028 Open-access full textSource: OpenAlex

  31. P3.15-007 A Retrospective Review of Small Cell Lung Cancer (SCLC) Patients Treated at Marmara University Hospital

    Journal of Thoracic Oncology, 2017

    DOI 10.1016/j.jtho.2017.09.1797 Open-access full textSource: OpenAlex

  32. Modified Glasgow prognostic score, prognostic nutritional index and ECOG score could be new prognostic factors for survival in metastatic gastric cancer

    Annals of Oncology, 2017

    DOI 10.1093/annonc/mdx369.049 Open-access full textSource: OpenAlex

  33. Changes in 18F-FDG-PET/CT tumor metabolism are not consistent with pathologic complete response in hormone-positive breast cancer

    Journal of B.U.ON., 2017

    PMID 29135102 1 citation (OpenAlex) Open-access full textSource: ORCID

  34. Analysis of survival and prognostic factors in metastatic colorectal cancer patients treated with first line bevacizumab.

    Journal of Clinical Oncology, 2017

    DOI 10.1200/jco.2017.35.15_suppl.e15009 1 citation (OpenAlex) Source: OpenAlex

  35. P1.03-040 Smokers Having Activating EGFR Mutant Non-Small Cell Lung Cancer Might Benefit from EGFR-TKI Treatment - Single Center Experience

    Journal of Thoracic Oncology, 2017

    DOI 10.1016/j.jtho.2017.09.844 Open-access full textSource: OpenAlex

  36. Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials

    Journal of Clinical Oncology, 2017

    DOI 10.1200/jco.2016.72.0946 PMID 28654365 150 citations (OpenAlex) Open-access full textSource: OpenAlex

  37. Systemic chemotherapy of advanced soft tissue sarcomas

    Journal of Oncological Sciences, 2017

    DOI 10.1016/j.jons.2017.05.001 7 citations (OpenAlex) Open-access full textSource: OpenAlex

  38. P2.03-042 EGFR Mutation and Erlotinib Efficacy in Turkish Oncoregistry

    Journal of Thoracic Oncology, 2017

    DOI 10.1016/j.jtho.2017.09.1293 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  39. Pretreatment PET/CT Standardized Uptake Values Play a Role in Predicting Response to Treatment and Survival in Patients with Small Cell Lung Cancer

    Oncology Research and Treatment, 2016

    DOI 10.1159/000444272 PMID 27030981 7 citations (Europe PMC) Open-access full textSource: OpenAlex

  40. Comparison of survival with somatostatin analog and chemotherapy and prognostic factors for treatment in 165 advanced neuroendocrine tumor patients with Ki-67 20% or less

    Anti-Cancer Drugs, 2016

    DOI 10.1097/cad.0000000000000445 PMID 27768606 7 citations (Europe PMC) Open-access full textSource: OpenAlex

  41. A study of the combination of oxaliplatin, capecitabine, and herceptin (trastuzumab) and chemoradiotherapy in the adjuvant setting in operated patients with HER2+gastric or gastro-esophageal junction cancer (TOXAG study)

    Journal of Clinical Oncology, 2016

    DOI 10.1200/jco.2016.34.4_suppl.tps182 21 citations (OpenAlex) Open-access full textSource: ORCID

  42. Biological Subtypes and Distant Relapse Pattern in Breast Cancer Patients After Curative Surgery (Study of Anatolian Society of Medical Oncology)

    Breast Care, 2016

    DOI 10.1159/000448186 PMID 27721711 15 citations (Europe PMC) Open-access full textSource: ORCID

  43. Comparison of WHO, RECIST 1.1, EORTC, and PERCIST criteria in the evaluation of treatment response in malignant solid tumors.

    Nuclear medicine communications, 2016

    DOI 10.1097/mnm.0000000000000401 PMID 26440568 49 citations (Europe PMC) Open-access full textSource: ORCID

  44. Changes in 18F-FDG-PET/CT tumor metabolism and prediction of pathologic complete response rates after neoadjuvant chemotherapy in hormone-positive breast cancer.

    Journal of Clinical Oncology, 2016

    DOI 10.1200/jco.2016.34.15_suppl.e12088 Open-access full textSource: OpenAlex

  45. Impact of adherence to antiemetic guidelines on the incidence of chemotherapy-induced nausea and vomiting and quality of life

    International Journal of Clinical Pharmacy, 2016

    DOI 10.1007/s11096-016-0393-3 PMID 27796777 21 citations (OpenAlex) Open-access full textSource: OpenAlex

  46. Benefit of Bevacizumab-Based Frontline Therapy in Patients with Metastatic Colorectal Cancer (mCRC): a Turkish Oncology Group Study

    Journal of Gastrointestinal Cancer, 2016

    DOI 10.1007/s12029-016-9823-7 PMID 27126591 2 citations (OpenAlex) Source: OpenAlex

  47. End-of-Life Considerations in Patients with Breast Cancer

    Springer eBooks, 2016

    DOI 10.1007/978-3-319-26012-9_34 Source: OpenAlex

  48. Oral Alım Sorunu Olan Kanser Hastalarında Beslenme

    Turkiye Klinikleri Medical Oncology - Special Topics, 2016

    Source: OpenAlex

  49. Burden of Metastatic Castration-Resistant Prostate Cancer (MCRPC) in Turkey

    Value in Health, 2016

    DOI 10.1016/j.jval.2016.09.2170 Open-access full textSource: OpenAlex

  50. PET ile Onkolojide Tedaviye Yanıtın Değerlendirilmesi: Medikal Onkolog Gözüyle

    Turkiye Klinikleri Nuclear Medicine - Special Topics, 2016

    Source: OpenAlex